Deccan Remedies Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 12.42 Cr
- Company Age 31 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
- Satisfied Charges ₹ 17.75 Cr
- Revenue Growth %
- Net Worth 2.96%
- Total Assets 141.40%
About Deccan Remedies
Deccan Remedies Ltd (DRL) is a Public Limited Indian Non-Government Company incorporated in India on 31 January 1994 and has a history of 31 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 12.42 Cr.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹17.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Deccan Remedies Ltd India are Dinesh Kejriwal as COMPANY SECRETARY and Akkali Kumar as Cfo. Arihant Baid, Addala Harsha, and Mohammed Rahman serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72200TG1994PLC016962
-
Company No.
016962
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
31 Jan 1994
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Deccan Remedies?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arihant Baid
|
Managing Director | 28-Nov-2022 | Current |
|
Dinesh Kejriwal
|
Company Secretary | 26-May-2023 | Current |
| Akkali Kumar | CFO | 30-Nov-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Mohammed Rahman
|
Director | 31-Jan-1994 | Current |
|
Addala Harsha
|
Director | 01-Mar-2023 | Current |
Financial Performance of Deccan Remedies.
Deccan Remedies Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 2.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deccan Remedies?
In 2023, Deccan Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gennex Laboratories LimitedArihant Baid and Dinesh Kejriwal are mutual person
-
Prudential Holdings Pvt. Ltd.Arihant Baid is a mutual person
-
Vab Realty Private Limited
Arihant Baid is a mutual person
-
Premier Industrial & Commercial Credit Pvt. Ltd.
Arihant Baid is a mutual person
-
Premier Fiscal Services Pvt Ltd
Arihant Baid is a mutual person
-
Armstrong Life Sciencess Private Limited
Addala Harsha is a mutual person
Charges (Loans)
₹20.00 Cr
₹17.75 Cr
Charges Breakdown by Lending Institutions
- Others : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2023 | Others | ₹5.00 Cr | Open |
| 16 Mar 2023 | Others | ₹15.00 Cr | Open |
| 01 Feb 1999 | Andhra Bank | ₹2.00 Cr | Satisfied |
| 26 Mar 1998 | Industrial Investment Bank Of India | ₹1.00 Cr | Satisfied |
| 20 Feb 1998 | Industrial Development Bank Of India | ₹3.75 Cr | Satisfied |
How Many Employees Work at Deccan Remedies?
Unlock and access historical data on people associated with Deccan Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deccan Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deccan Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
